MwanzoNATCOPHARM • NSE
add
Natco Pharma Ltd
Bei iliyotangulia
₹ 921.95
Bei za siku
₹ 917.05 - ₹ 977.00
Bei za mwaka
₹ 726.80 - ₹ 1,639.00
Thamani ya kampuni katika soko
174.45B INR
Wastani wa hisa zilizouzwa
elfu 958.77
Uwiano wa bei na mapato
9.22
Mgao wa faida
0.62%
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 12.21B | 13.95% |
Matumizi ya uendeshaji wa biashara | 5.22B | 16.26% |
Mapato halisi | 4.07B | 5.25% |
Kiwango cha faida halisi | 33.30 | -7.63% |
Mapato kwa kila hisa | 22.70 | 5.29% |
EBITDA | 5.09B | 3.21% |
Asilimia ya kodi ya mapato | 19.75% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 29.17B | 109.70% |
Jumla ya mali | 86.31B | 24.97% |
Jumla ya dhima | 10.18B | -3.29% |
Jumla ya hisa | 76.12B | — |
hisa zilizosalia | 179.12M | — |
Uwiano wa bei na thamani | 2.17 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 14.74% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Mac 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 4.07B | 5.25% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Natco Pharma is an Indian multinational pharmaceutical company based in Hyderabad. The company manufactures finished dosage formulations, active pharmaceutical ingredients and agrochemical products. It is a major producer of branded oncology medicines cardiology, diabetology and other pharma specialty drugs at affordable prices. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1981
Makao Makuu
Tovuti
Wafanyakazi
4,016
